Is the End of the Obesity Epidemic Near? People Lost Up to 85 Pounds Using New Weight Loss Drug
Eli Lilly's new weight loss drug, retatrutide, shows promising results in combating obesity. In a recent clinical trial, participants lost an average of 70.3 pounds, with many achieving significant weight loss. This development follows a trend initiated by earlier drugs like Ozempic and Wegovy, which have also contributed to changes in dietary habits among Americans.
- ▪Participants in the trial lost an average of 70.3 lbs over 80 weeks.
- ▪45.3% of participants achieved a weight loss of 30% or more.
- ▪The drug is part of a new wave of hormonal treatments for obesity and diabetes.
Opening excerpt (first ~120 words) tap to expand
Obesity Is the End of the Obesity Epidemic Near? People Lost Up to 85 Pounds Using New Weight Loss Drug Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy. Ronald Bailey | 5.22.2026 3:30 PM Share on FacebookShare on XShare on RedditShare by emailPrint friendly versionCopy page URL Add Reason to Google Media Contact & Reprint Requests <img src="https://d2eehagpk5cl65.cloudfront.net/img/c800x450-w800-q80/uploads/2026/05/obesity-decrease-v1-800x450.jpg" style="max-width: 100%; height: auto" width="1200" height="675" title="An illustration of a person standing on a scale" alt="An illustration of a person standing on a scale | Midjourney/Dragan Andrii/Dreamstime" /> (Midjourney/Dragan Andrii/Dreamstime) Rumors about the astonishing…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Reason.com.
Discussion
0 commentsMore from Reason.com
